DFX Intelligence

Zachary Bogue

Co-Founder and Managing Partnerat Dcvc· CA

As of 2026-09-30 · this person's identity; each section below carries its own date

Current roles: 4
Investments attributed: 3
Board seats: 1

Ask DFX about this View relationships Find contacts Investments Board seats

As of 2026-09-30 · this person's identity; each section below carries its own date

13 additional roles and seats

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Nothing material in the last 365 days. Last change: 15 Sep 2020, Latest Recursion Pharmaceuticals Form D equity offering ($236M) on 15 Sep 2020.

Relationship network

19 connected entities3 observed investment recordsinvestment records 2017 to 2020

From the roles sources name this person in, the investments a source attributes to them, and the boards and funds Form D names them on.

Some relationships on this record are counted rather than named here. They open with the full profile.

Click any name or line for the investment records and sources behind it. Line weight is investment records together; dashed lines are inferred.

Reading the network

Organization
Company
Fund or vehicle

›How strength and recency are read

Venture relationships are not scored. Each line names its claim: a round led or joined, a board seat or a filing that names the firm, a listing on a portfolio page (dated by when DFX saw it, never by when the investment was made), a disclosed LP commitment, or a co-investor pair counted from observed participations. Observed means a named source says so; Derived means DFX counted it from observed rows; Inferred means a match that may be wrong.

Darker lines were active in the last 24 months or are current; lighter lines are older or undated.

Ask DFX about this network

Which companies and boards is Zachary Bogue connected to?

How am I connected?

Name your firm, a company or a person, and DFX finds the published routes to Zachary Bogue: a shared portfolio company or board, a prior employer, a co-investor, a shared LP or service provider. Every step is a filed or published record with its source; none is a guess about who knows whom.

See how you connect to Zachary Bogue

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Drawing the relationship network…

Roles

3 current, 0 past

Dcvc Bio Managing Member
Feb 1, 2018 to present · “Schedule A: BOGUE, ZACHARY, MANAGING MEMBER, since 02/2018, ownership NA, control person Y”
Fact Form ADV
Dcvc Managing Member
Apr 1, 2012 to present · “Schedule A: BOGUE, ZACHARY, MANAGING MEMBER, since 04/2012, ownership D, control person Y”
Fact Form ADV
Dcvc Co-Founder and Managing Partner
? to present · “team page: Zachary Bogue / Co-Founder and Managing Partner”
Fact Firm website

Investments attributed to this person

Company	Round	Investor	Attribution	Date	Source
Recursion Pharmaceuticals, Inc.	Form D equity offering · $236M	Dcvc	strongly supported · board	Sep 15, 2020	Inference sec.gov
Recursion Pharmaceuticals, Inc.	Form D equity offering · $122M	Dcvc	strongly supported · board	Aug 13, 2019	Inference sec.gov
Recursion Pharmaceuticals, Inc.	Form D equity offering · $55.8M	Dcvc	strongly supported · board	Oct 6, 2017	Inference sec.gov

Board seats and vehicles

1 board, 16 vehicles

Recursion Pharmaceuticals, Inc. board seat on a deal Sep 15, 2020 Inference
DCVC VI Access IS, LLC Executive Officer Aug 25, 2026
Dcvc Bio Opportunity Fund, L.P. Executive Officer Nov 18, 2021
Data Collective II, LP Executive Officer Dec 21, 2012

Timeline

5 dated entries: events, attributed deals, board seats and role changes

Sep 15, 2020
Form D equity offering in Recursion Pharmaceuticals, Inc. (Dcvc)
Attributed investment Inference Recursion Pharmaceuticals, Inc. Form D
Aug 13, 2019
Form D equity offering in Recursion Pharmaceuticals, Inc. (Dcvc)
Attributed investment Inference Recursion Pharmaceuticals, Inc. Form D
Feb 1, 2018
Joined Dcvc Bio as Managing Member
Role began Fact Dcvc Bio Form ADV
Oct 6, 2017
Form D equity offering in Recursion Pharmaceuticals, Inc. (Dcvc)
Attributed investment Inference Recursion Pharmaceuticals, Inc. Form D
Apr 1, 2012
Joined Dcvc as Managing Member
Role began Fact Dcvc Form ADV